DavidPaulFivensonMDBoard Certified in Immunodermatology

Dermatology • Ann Arbor, MI

David Fivenson, MD, Dermatology, PLLC- President

Join to view full profile

Dr. Fivenson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fivenson's full profile

Already have an account?

Office
3200 W LIBERTY RD
Suite C5
Ann Arbor, MI 48103
Phone+1 734-222-9630

Education & Training

University of Cincinnati Medical Center/College of MedicineResidency, Dermatology, 1986 - 1989
University of California (San Diego) Medical CenterFellowship, Allergy and Immunology, 1985 - 1986
St Joseph Mercy Ann ArborInternship, Transitional Year, 1984 - 1985
University of Michigan Medical SchoolClass of 1984

Certifications & Licensure

MI State Medical License 1987 - 2027
OH State Medical License 1986 - 1990
American Board of Dermatology Dermatology
American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology

Awards, Honors, & Recognition

Newsweek best medical dermatologists in USA 2022-2023
America's Top Doctors Castle Connolly, 2002-2020
Top MD Consumers Checkbook
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) Start of enrollment: 2005 Mar 01
Completed
Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers Start of enrollment: 2005 Dec 01
Completed
Phase 2
The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis Start of enrollment: 2009 Nov 01
Completed
Phase 3
LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) Start of enrollment: 2010 Sep 01
Completed
Phase 3
Phase 3 Papulopustular Rosacea Study Start of enrollment: 2011 Dec 01
Completed
Phase 3
LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris Start of enrollment: 2012 May 01
Completed
Phase 2
LEO 90100 in the Treatment of Psoriasis Vulgaris Start of enrollment: 2012 May 01
Completed
Phase 2
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
Completed
Phase 3
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis Start of enrollment: 2015 Feb 01
Completed
Phase 3
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis Start of enrollment: 2017 Mar 21
Completed
Phase 3
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis Start of enrollment: 2017 Sep 21
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

82 citations
Prospective, single-blind, randomized, controlled study to assess the efficacy of the 585-nm flashlamp-pumped pulsed-dye laser and silicone gel sheeting in hypertrophi...
Gregory P. Wittenberg, Brian G. Fabian, Jodie Bogomilsky, Lonni R. Schultz, Earl J. Rudner
Archives of Dermatology. 1999-09-01
51 citations
Graftskin therapy in epidermolysis bullosa
David P. Fivenson, Lubomira Scherschun, Michelle Choucair, Debra KuKuruga, Janet Young
Journal of the American Academy of Dermatology. 2003-06-01
390 citations
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
Dedee F. Murrell, Sarah Dick, A. R. Ahmed, Masayuki Amagai, Maria A. Barnadas
Journal of the American Academy of Dermatology. 2008-06-01

Lectures

Recent Advances in Bullous Diseases
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Authored Content

Sunscreen Toxicity and Legislative Update from AADVMX 2021May 2021
Case Report: A 40-Year-Old Man with Vasculitic NeuropathyOctober 2020
Why Dermatologists Should Care About Climate ChangeMarch 2019
Why Dermatologists Should Care About Climate ChangeMarch 2019
WebsiteJanuary 2018
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow